Medtronic (NYSE:MDT) said today that it won FDA approval for its Advisa SR MRI-safe SureScan single-chamber pacemaker, and that it is launching the device in the U.S. The device will allow MRI scans of any region of the body as long as it is used with MRI-safe SureScan leads, the Fridley, Minn.-based company said. “MRI is […]
Cardiovascular
Welcome to MassDevice's Cardiovascular Hub, your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.
🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation
Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ LVADs save lives: So why aren’t more available?
+ How Medtronic uses nitinol to improve the structure and effectiveness of heart devices
+ How Abbott designed the world’s first dual-chamber leadless pacemaker system
+ J&J used RWE for expanded indications — and you can, too
+ 7 cardiology startups you need to know
Latest Cardiology News
Cardiac Dimensions launches clinical trial for Carillon mitral valve device
Cardiac Dimensions today said it launched a clinical trial of its Carillon device, which is designed to treat functional mitral valve regurgitation. The 120-patient Reduce FMR study is a prospective, double-blind, randomized multi-center trial, Kirkland, Wash.-based Cardiac Dimensions said. Patients are slated to be randomized on a 3:1 basis to receive the Carillon device and optimal drug […]
Sorin touts Freedom Solo aortic valve data
Sorin Group (BIT:SRN) said today that data from a 1-year study of its Freedom Solo stentless pericardial aortic valve showed positive safety and efficacy results. The 251-patient study looked at individuals in North America with aortic valve disease who are implanted with the device, the Milan, Italy-based company said. Results showed a mean reduction in gradient […]
Masimo plans to use pulse oximeter to review movie
Masimo (NSDQ:MASI) said last week that it plans to use its iSpO2 pulse oximeter to review 1st-time viewers reactions to the documentary “Personal Gold: An Underdog Story.” Select attendees of the documentary screening will receive a pulse oximeter to record their pulse and blood oxygenation during the film, the Irvine, Calif.-based company said. Afterwards, the documentary team […]
CardiAQ Valve touts TMVI procedure
CardiAQ Valve Technologies said yesterday that it successfully implanted its 2nd generation transcatheter bioprosthetic mitral heart valve. The procedure was performed in Tor Vergata Hospital in Rome, Italy on a 72-year-old male suffering from severe mitral regurgitation who was ineligible for alternate treatments, the Irvine, Calif.-based company said. “These untreatable patients are the reason I founded […]
ICD: New study shows low use, high benefit in older HF patients
A new study released in the Journal of the American Medical Association today reported that implantable cardioverter-defibrillators may be underutilized in elderly patients. Data from the 10,318-patient study, partially supported by Boston Scientific (NYSE:BSX), revealed that only 8.1% of eligible patients over 65 received ICDs within 1 year after experiencing a heart attack, despite the fact […]
TAVI: FDA approves Medtronic’s CoreValve Evolut R
Medtronic (NYSE:MDT) said today that the FDA granted pre-market approval for its CoreValve Evolut R replacement heart valve, less than a week after approving the competing Sapien 3 valve made by Edwards Lifesciences (NYSE:EW). The devices are 3rd-generation transcatheter aortic valve implants designed to treat leaky heart valves. Both the CoreValve Evolut R and the Sapien 3 are […]
Biosense Webster launches cardiac mapping system
Johnson & Johnson (NYSE:JNJ) subsidiary Biosense Webster said last Thursday that it launched the Carto 3 system Confidense 3D cardiac mapping module for use during catheter ablation procedures. The module uses a proprietary algorithm to speed up the process of multi-electrode cardiac mapping, the company said, streamlining a validation process that previously had to be done manually. […]
Biotronik launches U.S. study of Orsiro hybrid stent
Biotronik said it launched a U.S. investigational device exemption trial of its Orsiro hybrid drug-eluting stent, the Bioflow-V study. The Orsiro device’s coating includes 2 components, according to Biotronik: a passive element called ProBio designed to encapsulate the stent to minimize interaction between it and surrounding tissue, and an active combination of a limus anti-restenosis drug […]
Boston Scientific launches Emblem S-ICD trial
Boston Scientific (NYSE:BSX) said today that it’s launched a global clinical trial for its Emblem S-ICD in primary prevention patients with severely reduced cardiac function. The Untouched study is slated to enroll a minimum of 2,015 patients with no documented, life-threatening arrhythmic event who are at risk of sudden cardiac death. The 18-month study will compare […]
Medtronic touts 5-year Endurant AAA stent data
Medtronic (NYSE:MDT) said its Endurant abdominal aortic aneurysm stent is performing well, according to a 5-year follow-up study of the device. The announcement was made at the Society for Vascular Surgery’s annual meeting in Chicago last Saturday. The 5-year, 150-patient study data reported a 99.2% freedom from aneurysm related mortality and an 89% freedom from secondary […]